Modern Zombie Narratives

I have been thinking more about innovation as I’ve written the two essays on the history of warfarin.  In those essays, I consider the nature of the narratives that report, or carry, the history of warfarin.   As I work on my next essay on warfarin, I am looking at how choice of details affects the perception of “what happens.”  My premise is that it is the perceptions derived from innovation narratives that underlie policy claims for how government or law should support innovation, or what it is inventors do, and the role of universities and others in all of this.  That is, policy makers are not “in the flow” of innovation themselves, and rely on what they take to be plausible, if not canonical, accounts of innovation to inform their arguments.  In this, my premise goes, simplifying selection of key events and relationships carries more impact in policy formation than reports of experience from practicing inventors, entrepreneurs, and investigators.

We might observe that yes, inventors, entrepreneurs, and investigators, along with investors, lawyers, and executives, are able to miss details, too, and to repeat what they have heard as much as consider (or be willing to give voice to) what they experienced.  It’s not everyone who has the candor of Karl Paul Link to spread the credit around.  But there is not a single short narrative of warfarin that preserves his statements of credit, even though he gives them the place of honor in his account, and even though his account specifies what each materially did–motivate the change in lab direction (“MORE DEAD COWS!”), isolate the substance, characterize it, synthesize it, produce many variations, test these, find others that work better, figure better ways to produce those.  World success.

There is no university IP policy that states outright:  “Historically, talented and dedicated students working together in teams distributed over time offer a tremendous prospect for changing the world through new technology.  Therefore, it is our policy to provide resources to those faculty who excel at instructing, recruiting, directing, and motivating student talent in research and outreach activities.”   Doesn’t exist.

We might think it a topic for a comedy movie, of a set of officials in the 17th century who establish policy for voyages of discovery by reading sailing stories, or, better, reading statistical studies of sailing stories.  Continue reading

Posted in Social Science | Comments Off on Modern Zombie Narratives

The Policy and the Damage Done

Here is a state law pertaining to employer claims to employee inventions:

Sec. 2. Employee rights to inventions ‑ conditions). (1) A provision in an employment agreement which provides that an employee shall assign or offer to assign any of the employee’s rights in an invention to the employer does not apply to an invention for which no equipment, supplies, facilities, or trade secret information of the employer was used and which was developed entirely on the employee’s own time, unless (a) the invention relates (i) to the business of the employer, or (ii) to the employer’s actual or demonstrably anticipated research or development, or (b) the invention results from any work performed by the employee for the employer. Any provision which purports to apply to such an invention is to that extent against the public policy of this State and is to that extent void and unenforceable. The employee shall bear the burden of proof in establishing that his invention qualifies under this subsection.
(2) An employer shall not require a provision made void and unenforceable by subsection (1) of this Section as a condition of employment or continuing employment. This Act shall not preempt existing common law applicable to any shop rights of employers with respect to employees who have not signed an employment agreement.
(3) If an employment agreement entered into after January 1, 1984, contains a provision requiring the employee to assign any of the employee’s rights in any invention to the employer, the employer must also, at the time the agreement is made, provide a written notification to the employee that the agreement does not apply to an invention for which no equipment, supplies, facility, or trade secret information of the employer was used and which was developed entirely on the employee’s own time, unless (a) the invention relates (i) to the business of the employer, or (ii) to the employer’s actual or demonstrably anticipated research or development, or (b) the invention results from any work performed by the employee for the employer.

This is a typical set of requirements. First, a limitation on the claims an employer can make in patent rights of employees.  Second, a limitation on making a claim outside the limitation as a condition of employment.  Third, a requirement that if a claim is made a condition of employment, then the employee must get written notice of the limitation.

[There are arguments out there that these sorts of laws–in eight states or so–actually expand an employer’s right to claim inventions over federal common law. Federal common law, for instance, does not recognize use of an employer’s resources as a basis for a claim to ownership of inventions–all that might get in equity is a “shop right”–a right for the employer to practice the invention royalty-free.

The thing that’s the more interesting is that university officials end-run the law by asserting that a university patent licensing function means that all inventions any employee might make come within the business of the employer or its anticipated future development, which now seeks to make money from any invention an employee might make. Such a move simply defies the law and attempts to transform the business upon which an organization is founded become any dealings an organization may have with patents on inventions.] Continue reading

Posted in IP, Technology Transfer | Tagged , , , , , | Comments Off on The Policy and the Damage Done

On the warfarin path, part 2

The first essay in this series is here. Let’s turn now in our warfarin narratives to a few more developed accounts, including Karl Paul Link’s own published account. [I have corrected a biographical error–Prof. Link’s Ph.D. was from Wisconsin, not Johns Hopkins (where William Tottingham, his Ph.D. advisor, had studied). See here for an account.]

An account of the development of warfarin is included as part of a series of Biographical Memoirs of important scientists, including Karl Paul Link’s, published by the National Academies of Science. The lead paragraph connects Prof Link’s work and his commercial successes:

KARL PAUL LINK was a carbohydrate chemist and plant biochemist, whose research changed direction abruptly when he initiated work on the isolation and characterization of the hemorrhagic factor produced in spoiled sweet clover hay. The isolation of a modified coumarin as the causative agent led Link and his colleagues to the synthesis of a variety of anticoagulants that have had wide medical application as anticlotting agents and that have also proved highly effective as rodenticides.

A feature of note in this summary is the abrupt change in direction in Link’s research.  Continue reading

Posted in Bayh-Dole, Technology Transfer | Tagged , | 1 Comment

Creepiness is next to greediness

It is true that some criticisms of university technology transfer offices are misdirected.  Criticism, however, is not merely a sign of ill will or ignorance or organized special interest lulz of everything good.  Criticism also serves the role of debate about the future, accounting for claims, and responsibility for choices.  In this form, criticism plays an essential role.  Without criticism working through the issues, we get monoculture, whitewash, hand-waving, and self-interest covered by nice-sounding words.

The fact of criticism does not have much at all to do with the value of the portfolios universities hold.  Continue reading

Posted in Bayh-Dole, IP, Technology Transfer | Comments Off on Creepiness is next to greediness

Opening up subject invention reporting

In the last post, I suggested a new reporting for subject inventions.  Nothing like this presently exists.  The ubiquitous university licensing survey aggregates information and therefore becomes useless for tracking subject inventions.  And misleading.  Continue reading

Posted in Bayh-Dole, Metrics, Technology Transfer | Comments Off on Opening up subject invention reporting

Improving periodic reporting

Bayh-Dole is not a perfect law by any means.  But what are the weak points?  Where can things be improved?  Here is one suggestion.  In 35 USC 202(c)(5) funding agreements are required to have language to permit agencies to request periodic reporting on utilization or efforts at obtaining utilization.  Fine and good.  But then this information is locked up under FOIA, so no one can get at it.  This prevents public accountability, in particular, of university claimed subject inventions.   The provision should be divided so that the portion applicable to universities and non-profits goes to (c)(7), and is further divided so that the portion of reporting that pertains to march-in investigations may be held under FOIA, but not routine periodic reporting.  Further, as regards non-profits, the public should be provided with an explanation for why an agency does not require periodic reporting, on the model of 35 USC 202(b).   Continue reading

Posted in Bayh-Dole, Metrics | Comments Off on Improving periodic reporting

What No Law Can Do

I’ve worked through a lot of things about Bayh-Dole recently, including looking at the various claims coming forward about how Bayh-Dole works in the context of the Stanford v. Roche case.    In particular I am interested in the amicus briefs filed by university patent administrators.  They have used a range organizations to front their claims–AUTM, AAU, APLU, and NACUA, among others.  These are part and parcel of the same patent administration outlook, and their arguments reflect this common origin.  Continue reading

Posted in Bayh-Dole | Comments Off on What No Law Can Do

On the warfarin path

We frame our expectations and our insights by the stories we tell.  This is true as well of the stories of innovation.   How does something new come into the world and reshape things?  We have two primary narratives–bane and boon–one, in which a bane is turned away by the status quo, and the other in which a boon is found or made to advantage.  Variations a numerous.  Banes from the outside, like Grendel tearing up Hrothgar’s hall, and banes from within, like heresies and seditions ruining a good thing.  Boons of discovery, like those of sea voyages and research, and boons of cleverness, by which a new thing is made.  And we have warnings for both.  How the things we fear may be for our benefit, or how what we make can go bad and even detest us for it (Caliban, Frankenstein’s monster). Continue reading

Posted in IP, Social Science, Technology Transfer | Tagged , , , , | 5 Comments

Dealing with university patent accumulation

A while ago I worked through the idea of patent accumulation as a problem for economic development. See What Happens Here Is Excluded Here.

The gist is, if one accumulates research patents primarily in one’s own jurisdiction and these go generally unlicensed (or otherwise made available), then the overall effect is to give *all other jurisdictions* an advantage globally in the development and use of the invention.

This is particularly important for research inventions because they often are so disconnected from commerce already (and that’s one of their virtues!).  Continue reading

Posted in IP, Technology Transfer | Comments Off on Dealing with university patent accumulation

When universities come trolling

Here is a question.  Is it a violation of Bayh-Dole for a university to sue a company for infringement of a subject invention for a monetary settlement?

Bayh-Dole sets out its objectives in 35 USC 200.  We are not talking here about the secret objectives that university patent administrators believe were the real objectives of the law.  No, here we are looking at public text and reasons. Continue reading

Posted in Bayh-Dole, IP | Comments Off on When universities come trolling